MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds received
related to employee...
$3,797K
(88.06%↑ Y/Y)
Net cash provided by
financing activities
$3,797K
(-50.54%↓ Y/Y)
(decrease) increase in
cash, cash...
-$118,751K
(-211.34%↓ Y/Y)
Canceled cashflow
$3,797K
Stock-based compensation
$72,791K
(556.01%↑ Y/Y)
Accrued liabilities
$12,218K
(658.41%↑ Y/Y)
Accounts payable
$6,802K
(1810.67%↑ Y/Y)
Operating lease
right-of-use assets and lease...
$365K
(1360.00%↑ Y/Y)
Unrealized foreign
exchange loss (gain)
-$190K
(-184.82%↓ Y/Y)
Depreciation
$44K
(76.00%↑ Y/Y)
Maturities and sales of
short-term investments
$177,293K
(10.44%↑ Y/Y)
Net cash used in
operating activities
-$122,291K
(-99.93%↓ Y/Y)
Canceled cashflow
$92,410K
Net cash (used in)
provided by investing...
-$238K
(-100.15%↓ Y/Y)
Effect of exchange rate
changes on cash
-$19K
(-150.00%↓ Y/Y)
Canceled cashflow
$177,293K
Net loss
-$189,424K
(-201.09%↓ Y/Y)
Prepaid expenses and
other current assets
$11,014K
(695.35%↑ Y/Y)
Accrued compensation
-$7,852K
(-3.48%↓ Y/Y)
Amortization of discount on
short-term investments
$4,217K
(42.18%↑ Y/Y)
Other current
liabilities
-$2,315K
(-121.32%↓ Y/Y)
Purchase of short-term
investments
$177,286K
Purchases of property and
equipment
$245K
(-41.94%↓ Y/Y)
Back
Back
Cash Flow
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
source: myfinsight.com